Skip to content

An analysis of the efficacy, safety and cost-effectiveness of multimodal analgesia by ultrasonography of transverse abdominis block after laparoscopic cholecystectomy

An analysis of the efficacy, safety and cost-effectiveness of multimodal analgesia by ultrasonography of transverse abdominis block after laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034001
Enrollment
Unknown
Registered
2020-06-20
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

An analysis of the efficacy ,safety and cost-effectiveness of multimodal analgesia by ultrasonography of transverse abdominis block after laparoscopic cholecystectomy

Interventions

experimental group:PCIA+TAPB

Sponsors

The Second Affiliated Hospital of Wannan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years, gender is not limited; 2. Patients who plan to undergo laparoscopic cholecystectomy and require postoperative analgesia; 3. American Society of Anesthesiologists (ASA) Classification I-II; 4. No communication barriers, can cooperate with the implementation of intervention and understand the use of relevant scales, and can operate patient-controlled analgesia equipment; 5. Subjects participate voluntarily and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. There are contraindications of nerve block (such as puncture site infection); 2. Preoperative examination of patients with tumors indicates that the tumors have metastasis; 3. Patients with severe liver and kidney diseases, coagulation dysfunction, etc.; 4. History of previous abdominal surgery or trauma; 5. Long-term use of sedative and analgesic drugs or alcohol, sedative and analgesic drug addicts; 6. Patients suffering from chronic pain; 7. Drug allergy patients used in the study; 8. Mental disorders that interfere with perception and pain assessment; 9. Analgesics taken before operation; 10. Pregnant or lactating women; 11. Participating in other clinical studies within 30 days; 12. Other circumstances considered inappropriate for the study by the investigator.

Design outcomes

Primary

MeasureTime frame
Abdominal wall pain at rest;Pain in the abdominal wall during coughing;Ramsay score;Poseoperative analgesia satisfaction of patients;Analgesia pump pressure times in 24 hours;the usage of analgesic drug in 24 hours;Whether to remove analgesia pump due to adverse reactions;Additional postoperative analgesia requirements;Total hospitalization expenses;

Secondary

MeasureTime frame
postoperative hospitalization;

Countries

China

Contacts

Public ContactLiming Dai

The Second Affiliated Hospital of Wannan Medical College

645497123@qq.com+86 15375537838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026